Navigation Links
Champions Oncology Reports Financial Results for the Year Ended April 30, 2012

>38%Research and development



1%Sales and marketing



170%General and administrative



18%  Loss from Operations($9,065)($5,235)73%Other Income



-72%  Net Loss before income tax expense($8,663)($3,791)129%Income taxes



-118%  Net Loss($8,661)($3,802)128%  Earnings per share- basic and diluted($0.19)($0.11)73%Average Shares outstanding- basic and diluted


33,774,000 Condensed Consolidated Balance Sheets (Unaudited)At April 30, 20122011Cash and cash equivalents


$10,457Accounts receivable


585Other current assets


793  Total current assets5,54311,835Restricted cash


-Property and equipment, net




669  Total assets$6,922$12,650Accounts payable and accrued liabilities


$1,882Deferred revenue


1,618  Total current liabilities3,4863,500Warrant liability


972Redeemable common stock


8,159Stockholders' equity (deficit)


19  Total liabilities, redeemable common stock and stockholders' equity (deficit)($6,922)($12,650) Condensed Consolidated Statements of Cash Flows (Unaudited)Year Ended April 3020122011Cash flows from operating activities:Net Loss


($3,802)Adjustments to reconcile net cash used in operations:  Stock-based compensation expense


3,133  Depreciation expense


42  Change in fair value of warrant liability


36  Other adjustments


12  Changes in operating assets and liabilities


525Net cash used i

SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
8. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
9. GeneLink Reports First Quarter 2012 Financial Results
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Vermillion Reports First Quarter 2012 Results
Post Your Comments:
(Date:8/19/2014)... (PRWEB) August 19, 2014 XenoTech ... fast and cost-effective metabolite production from bioactive small ... chemistry platform, the technology enables convenient and timely ... According to XenoTech’s Vice President of Commercial Operations, ... for assessing clinical risk can be measured directly ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics ... ICOTF), today reported results of its Oral Amphotericin ... HIV reservoirs.  The study, conducted by ImmuneCarta®, the ... in vitro effectiveness of Oral Amp B ... present in individuals despite intensive treatment with antiretroviral ...
(Date:8/18/2014)... Md. , Aug. 18, 2014 /PRNewswire/ ... maker of advanced consumer medical devices said ... was interviewed by CEOLIVE.TV as part ... The entire interview is available at ... Dr. Kotak explains to investors the unique ...
(Date:8/18/2014)... According to the new ... (Municipal Wastewater Treatment and Industrial Wastewater Treatment), By ... By Configuration (Internal/Submerged and External/Sidestream), and By Region-Trends ... market for membrane bioreactor systems is projected to ... CAGR of 15.28% between 2014 and 2019. ...
Breaking Biology Technology:Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3
... As part of the,"SCIENCEsuisse" project, is presenting ... of disciplines. The focus is on,Switzerland,s high international ... SRG SSR idee suisse initiative, in collaboration with,the ... to give readers an insight into what,scientists are ...
... Strains A & B In,15 Minutes, Each year ... ill with "the,flu." Misdiagnosis of the flu is common ... this, overuse and unnecessary,use of antibiotics may be a ... This flu season, a new rapid flu test can ...
... Nov. 11 PointCross Inc., responding to ... Pharmaceuticals R&D industries, has released,a software catalyst ... business and technical solutions with extreme speed ... leading collaboration platform for,enterprise users. Larger global ...
Cached Biology Technology:25 Short Films About Top-Level Research on 2MultiVu Video Feed: New Rapid Test to Diagnose Flu May Help With Upcoming Flu Season 2PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time 2
(Date:8/19/2014)... scientists have identified a biomarker strongly associated with ... is resistant to many types of chemotherapy. The ... target for new therapeutics designed to treat this ... data taken from The Cancer Genome Atlas, molecular ... used powerful computational and bioinformatics techniques to detect ...
(Date:8/19/2014)... during warm phases and became extinct during cold phases, ... link between marine crocodilian diversity and the evolution of ... million years. , The research, led by Dr ... formerly from the University of Bristol, UK is published ... are ,cold-blooded, animals that mainly live in fresh waters ...
(Date:8/19/2014)... Anyone who has ever had a glass of fizzy ... the air. But in a finding with wide industrial ... push some particles down into the liquid as well. ... aerosol droplets, so we were surprised, and fascinated, to ... the same process injected tiny oil droplets into the ...
Breaking Biology News(10 mins):Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Evolution of marine crocodilians constrained by ocean temperatures 2Bubbling down: Discovery suggests surprising uses for common bubbles 2Bubbling down: Discovery suggests surprising uses for common bubbles 3
... psychological society in the world, will grant its ... to Psychology" to Dr Friederike Range of the ... Medicine, Vienna (Vetmeduni Vienna). The award is recognition ... will be made in August 2012 at a ...
... of rare, endemic species in the Central Andes remain ... climate change, according to a Duke University-led international study. ... particularly vulnerable to changes in the environment or climate. ... percent of the areas with high numbers of these ...
... New York, NY (January 26, 2012) Researchers at the ... variation that raises the risk of developing serious necrotic jaw ... of osteoclastic inhibitors. The discovery paves the way for a ... drugs. The study appears in the online version of the ...
Cached Biology News:Dancing with wolves -- prestigious award goes to a scientist at the Vetmeduni Vienna 280 percent of 'irreplaceable' habitats in Andes unprotected 2Study pinpoints genetic variation that raises a risk linked to bisphosphonates 2Study pinpoints genetic variation that raises a risk linked to bisphosphonates 3
... Virgin, optically clear polystyrene with frosted ... coordinates for cell counting. 100% integrity ... a new product number, created to ... showing no availability yet, please order ...
... surface is produced by a patented microwave ... giving more consistent, even cell attachment, increased ... attachment and growth uunder difficult conditions, including ... may provide a more ecominic alternative to ...
... system, 100-240 V, uses xMAP technology for ... proteins and peptides in one microplate well. ... to 100 color-coded bead sets, each of ... reactant (enzyme substrates, receptors, antigens, or antibodies) ...
Biology Products: